NCT05430867: Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease
- State
- State not given
- Phase
- Phase 4
- People
- 150 planned
- Started
- 1 Jul 2022
- Primary completion
- 1 Jul 2024
- Arms
- Memantine combined with GV-971 group
- Results
- None posted
- 24 Jun 2022: Trial registered